Skip to content

Enhanced Adenosine Biosynthesis in Paecilomyces hepiali Through Strain Evolution and Transcriptomic Insights.

Aug 2026 · Biotechnology and Bioengineering · 0 citations · 42 references
Medicine

TL;DR

An integrated strategy combining protoplast-based strain evolution, medium optimization, and transcriptomic analysis to enhance adenosine biosynthesis in P. hepiali is developed and transcriptomic insights into adenosine biosynthesis are provided and a practical framework for improving fungal nucleoside cell factories is established.

Abstract

Adenosine is a major bioactive nucleoside and quality marker in cordyceps-derived fungal products, but its efficient biosynthesis in Paecilomyces hepiali remains limited by insufficient strain performance and incomplete understanding of metabolic regulation. Here, we developed an integrated strategy combining protoplast-based strain evolution, medium optimization, and transcriptomic analysis to enhance adenosine biosynthesis in P. hepiali. Efficient protoplast preparation was achieved using 48 h seed cultures digested with 1% driselase and 1% yatalase at 28°C for 7 h, and 40 s ultraviolet irradiation was selected for mutant library construction. A stable mutant, P. hepiali A3, produced 65.32 mg/L adenosine, representing a 31.62% increase over the parental strain. Subsequent response surface optimization identified maltose, peptone, and aspartic acid as key nutritional factors, increasing the adenosine titer to 170.41 mg/L in shake flasks and 191.36 mg/L in a 5-L bioreactor. Comparative transcriptomic analysis revealed extensive metabolic remodeling involving central carbon metabolism, ribose precursor supply, purine nucleotide metabolism, and sterol biosynthesis. Upregulation of ribose-5-phosphate isomerase RPIB and downregulation of ADA related to purine degradation were associated with enhanced purine nucleoside accumulation. These results provide transcriptomic insights into adenosine biosynthesis and establish a practical framework for improving fungal nucleoside cell factories.

View source

Similar papers

Oct 2026

Engineering 4-Vinylcatechol Biosynthesis in Escherichia coli Through Host-Enzyme Combination.

De novo biosynthesis of 4-vinylcatechol (VCAT), a valuable bio-based monomer and potent antioxidant, has emerged as a crucial objective due to its profound industrial and pharmacological significance. However, its biosynthesis is frequently hindered by limited precursor availability. In this study, we developed a highl...

E. Kaynak, Merve Seven, Hüseyin Balcı et al. · 0 citations
Open access Oct 2026

Metabolic Engineering of Yarrowia lipolytica for De Novo Biosynthesis of Umbelliferone

Umbelliferone, a key precursor for the biosynthesis of high-value furanocoumarin derivatives, is produced via the shikimate pathway. The oleaginous yeast Yarrowia lipolytica possesses an inherently robust shikimate pathway; however, de novo biosynthesis of umbelliferone in this microbial chassis has not been realized t...

Feng-Liu Lu, Ying Luo, Zhen-Ming Lei et al. · 0 citations
Sep 2026

Efficient Production of Vanillyl Alcohol in Escherichia coli via Protein and Pathway Engineering.

Vanillyl alcohol (VNA) is a high-value compound used in the pharmaceutical industry and other fields. Its microbial de novo biosynthesis is severely limited by the low catalytic efficiency of O-methyltransferase. Here, we constructed a V314I mutant of caffeate O-methyltransferase via structure-guided protein engineerin...

Jin-Yi Li, Yong Du, Jia Wang et al. · 0 citations
Sep 2026

High-Level Terpene Production via a Novel Actinomycetota-Derived MVA Pathway in E. coli.

A genomically integrated Mevalonate (MVA) pathway from Actinomycetota in E. coli BL21(DE3) is developed to enhance terpene precursor supply and provides potential reservoir of diverse chassis for the industrial production of terpenoid-derived compounds.

Wen-Chao Liu, Xueying Tian, Wai-Chuen Wong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.